Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure...
4 insider sale filings on record · latest filing 2026-09-17.
No open-market insider purchases (SEC Form 4 code P) on record for KMDA.